Get the Stockscreener App
15.40
4.64%
-0.75
After Hours:
15.37
-0.03
-0.19%
Oruka Therapeutics Inc stock is traded at $15.40, with a volume of 69,090.
It is down -4.64% in the last 24 hours and up +10.39% over the past month.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
See More
Previous Close:
$16.15
Open:
$16.15
24h Volume:
69,090
Relative Volume:
0.33
Market Cap:
$576.74M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.81%
1M Performance:
+10.39%
6M Performance:
+33.33%
1Y Performance:
-40.77%
1-Day Range:
$15.22
$16.15
1-Week Range:
$15.22
$16.47
52-Week Range:
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Name
Oruka Therapeutics Inc
Sector
Industry
Phone
650-606-7910
Address
855 OAK GROVE AVE., MENLO PARK
Compare ORKA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
15.40 | 590.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-25 | Initiated | BTIG Research | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Oct-11-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | H.C. Wainwright | Buy |
| Sep-17-24 | Initiated | Leerink Partners | Outperform |
| Sep-16-24 | Initiated | TD Cowen | Buy |
| Sep-13-24 | Initiated | Jefferies | Buy |
| Feb-27-18 | Initiated | Ascendiant Capital Markets | Buy |
| Oct-09-13 | Initiated | Dawson James | Buy |
View All
Oruka Therapeutics Inc Stock (ORKA) Latest News
Is Oruka Therapeutics Inc. stock entering bullish territory2025 Market Overview & Daily Price Action Insights - Newser
Ranking Oruka Therapeutics Inc. among high performing stocks via toolsStop Loss & Weekly High Potential Stock Alerts - Newser
What does recent volatility data suggest for Oruka Therapeutics Inc.Market Sentiment Review & Growth Focused Investment Plans - Newser
Why Oruka Therapeutics Inc. is moving todayJuly 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Short interest data insights for Oruka Therapeutics Inc.2025 Key Lessons & High Accuracy Investment Signals - Newser
Is Oruka Therapeutics Inc. reversing from oversold territory2025 Price Targets & Smart Money Movement Alerts - Newser
Best data tools to analyze Oruka Therapeutics Inc. stockRisk Management & Free Expert Verified Stock Movement Alerts - Newser
Historical volatility pattern of Oruka Therapeutics Inc. visualizedJuly 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Chart overlay techniques for tracking Oruka Therapeutics Inc.July 2025 Sentiment & Expert Verified Movement Alerts - Newser
Sector ETF performance correlation with Oruka Therapeutics Inc.Market Trend Review & Daily Stock Momentum Reports - Newser
Can Oruka Therapeutics Inc. rally from current levelsQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
does oruka therapeutics inc. qualify in momentum factor screeningPortfolio Value Summary & Low Volatility Stock Suggestions - Newser
How to monitor Oruka Therapeutics Inc. with trend dashboardsJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
Will a bounce in Oruka Therapeutics Inc. offer an exitWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser
Will Oruka Therapeutics Inc. outperform tech stocksRate Cut & Weekly Consistent Profit Watchlists - Lancaster City Council
Oruka Therapeutics Inc. stock chart pattern explained2025 Price Momentum & Weekly High Return Forecasts - Newser
OMERS ADMINISTRATION Corp Acquires 25,100 Shares of Oruka Therapeutics, Inc. $ORKA - MarketBeat
How to read the order book for Oruka Therapeutics Inc.CPI Data & Fast Gaining Stock Strategy Reports - Newser
Will Oruka Therapeutics Inc. outperform the marketMarket Growth Summary & Stock Portfolio Risk Management - Newser
Oruka Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Trade Ideas & Smart Money Movement Alerts - Newser
Oruka Therapeutics Inc Stock (ORKA) Financials Data
There is no financial data for Oruka Therapeutics Inc (ORKA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):